Terms: = Lymphoma AND TNFRSF14, Q92956, 8764, ENSG00000157873, TR2, ATAR, LIGHTR, HVEM, HVEA
79 results:
1. Follicular lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
[TBL] [Abstract] [Full Text] [Related]
2. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract] [Full Text] [Related]
3. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
4. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
[TBL] [Abstract] [Full Text] [Related]
5. Combined Reverse-Transcriptase Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing Analyses to Assign Unclassified BCL2
Sesboue C; Galtier J; Jeanneau M; Chauvel A; Laharanne E; Amintas S; Merlio JP; Bouabdallah K; Gros FX; de Leval L; Gros A; Parrens M
Mod Pathol; 2023 Feb; 36(2):100043. PubMed ID: 36853790
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of histological and molecular features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.
Lee J; Han JH; Lee CH; Park HS; Min SK; Lee H; Cho U; Yoon SE; Kim SJ; Kim WS; Cho J
Virchows Arch; 2023 May; 482(5):849-858. PubMed ID: 36656392
[TBL] [Abstract] [Full Text] [Related]
7. Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study.
Michot JM; Quivoron C; Sarkozy C; Danu A; Lazarovici J; Saleh K; El-Dakdouki Y; Goldschmidt V; Bigenwald C; Dragani M; Bahleda R; Baldini C; Arfi-Rouche J; Martin-Romano P; Tselikas L; Gazzah A; Hollebecque A; Lacroix L; Ghez D; Vergé V; Marzac C; Cotteret S; Rahali W; Soria JC; Massard C; Bernard OA; Dartigues P; Camara-Clayette V; Ribrag V
Am J Hematol; 2023 Apr; 98(4):645-657. PubMed ID: 36606708
[TBL] [Abstract] [Full Text] [Related]
8. Follicle Center lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center lymphoma (PCFCL).
Saksena A; Jain A; Pack SD; Kim J; Lee I; Tyagi M; Xi L; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2023 Mar; 47(3):409-419. PubMed ID: 36461146
[TBL] [Abstract] [Full Text] [Related]
9. Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk.
Wang X; Nissen M; Gracias D; Kusakabe M; Simkin G; Jiang A; Duns G; Sarkozy C; Hilton L; Chavez EA; Segat GC; Wong R; Kim J; Aoki T; Islam R; May C; Hung S; Tyshchenko K; Brinkman RR; Hirst M; Karsan A; Freeman C; Sehn LH; Morin RD; Roth AJ; Savage KJ; Craig JW; Shah SP; Steidl C; Scott DW; Weng AP
Nat Commun; 2022 Nov; 13(1):6772. PubMed ID: 36351924
[TBL] [Abstract] [Full Text] [Related]
10. Transformation of FL into DLBCL with a PMBL gene expression signature.
Loveday T; Duns G; Rimsza LM; Rech KL; Cook JR; Robetorye RS; Rosenthal AC; Ramsower CA; Yip TK; McKinney CL; Swerdlow SH; Bhavsar S; Steidl C; Gibson SE
Blood Adv; 2023 Mar; 7(6):893-899. PubMed ID: 36240289
[TBL] [Abstract] [Full Text] [Related]
11. Pediatric-Type Indolent B-Cell lymphomas With Overlapping Clinical, Pathologic, and Genetic Features.
Lim S; Lim KY; Koh J; Bae JM; Yun H; Lee C; Kim YA; Paik JH; Jeon YK
Am J Surg Pathol; 2022 Oct; 46(10):1397-1406. PubMed ID: 35834399
[TBL] [Abstract] [Full Text] [Related]
12. m6A-Regulator Expression Signatures Identify a Subset of Follicular lymphoma Harboring an Exhausted Tumor Microenvironment.
Zhang T; Liu H; Gao F; Gong W; Cui Y; He J; Li L; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Zhang H; Wang X
Front Immunol; 2022; 13():922471. PubMed ID: 35734168
[TBL] [Abstract] [Full Text] [Related]
13. A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile.
Salmeron-Villalobos J; Egan C; Borgmann V; Müller I; Gonzalez-Farre B; Ramis-Zaldivar JE; Nann D; Balagué O; López-Guerra M; Colomer D; Oschlies I; Klapper W; Glaser S; Ko YH; Bonzheim I; Siebert R; Fend F; Pittaluga S; Campo E; Salaverria I; Jaffe ES; Quintanilla-Martinez L
Blood Adv; 2022 Aug; 6(16):4661-4674. PubMed ID: 35609565
[TBL] [Abstract] [Full Text] [Related]
14. SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups.
Guo B; Huang Y; Duan Y; Liao C; Cen H
Cancer Med; 2022 Mar; 11(5):1281-1291. PubMed ID: 35106936
[TBL] [Abstract] [Full Text] [Related]
15. Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort.
Oishi N; Segawa T; Miyake K; Mochizuki K; Kondo T
Histopathology; 2022 Apr; 80(5):820-826. PubMed ID: 35038193
[TBL] [Abstract] [Full Text] [Related]
16. [Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma].
Vogelsberg A; Steinhilber J; Mankel B; Federmann B; Schmidt J; Montes-Mojarro IA; Hüttl K; Rodriguez-Pinilla M; Baskaran P; Nahnsen S; Piris MA; Ott G; Quintanilla-Martinez L; Bonzheim I; Fend F
Pathologe; 2021 Dec; 42(Suppl 2):122-128. PubMed ID: 34671837
[TBL] [Abstract] [Full Text] [Related]
17. Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
Kaji D; Kusakabe M; Sakata-Yanagimoto M; Makishima K; Suehara Y; Hattori K; Ota Y; Mitsuki T; Yuasa M; Kageyama K; Taya Y; Nishida A; Ishiwata K; Takagi S; Yamamoto H; Asano-Mori Y; Ubara Y; Izutsu K; Uchida N; Wake A; Taniguchi S; Yamamoto G; Chiba S
Br J Haematol; 2021 Nov; 195(4):585-594. PubMed ID: 34558064
[TBL] [Abstract] [Full Text] [Related]
18. Frequent mutated B2M, EZH2, IRF8, and tnfrsf14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.
de Groen RAL; van Eijk R; Böhringer S; van Wezel T; Raghoo R; Ruano D; Jansen PM; Briaire-de Bruijn I; de Groot FA; Kleiverda K; Te Boome L; Terpstra V; Levenga H; Nicolae A; Posthuma EFM; Focke-Snieders I; Hardi L; den Hartog WCE; Bohmer LH; Hogendoorn PCW; van den Berg A; Diepstra A; Nijland M; Lugtenburg PJ; Kersten MJ; Pals ST; Veelken H; Bovée JVMG; Cleven AHG; Vermaat JSP
Blood Adv; 2021 Oct; 5(19):3760-3775. PubMed ID: 34478526
[TBL] [Abstract] [Full Text] [Related]
19. Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma.
Bastidas Torres AN; Melchers RC; Van Grieken L; Out-Luiting JJ; Mei H; Agaser C; Kuipers TB; Quint KD; Willemze R; Vermeer MH; Tensen CP
Haematologica; 2022 Jul; 107(7):1619-1632. PubMed ID: 34382383
[TBL] [Abstract] [Full Text] [Related]
20. c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma.
Bouroumeau A; Bussot L; Bonnefoix T; Fournier C; Chapusot C; Casasnovas O; Martin L; McLeer A; Col E; David-Boudet L; Lefebvre C; Algrin C; Raskovalova T; Jacob MC; Vettier C; Chevalier S; Callanan MB; Gressin R; Emadali A; Sartelet H
J Pathol Clin Res; 2021 Nov; 7(6):604-615. PubMed ID: 34374220
[TBL] [Abstract] [Full Text] [Related]
[Next]
